Patents by Inventor Keith G. Weinstock

Keith G. Weinstock has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Nucleic acid and amino acid sequences relating to for diagnostics and therapeutics
    Patent number: 7504490
    Abstract: The invention provides isolated polypeptide and nucleic acid sequences derived from Aspergillus fumigatus that are useful in diagnosis and therapy of pathological conditions; antibodies against the polypeptides; and methods for the production of the polypeptides. The invention also provides methods for the detection, prevention and treatment of pathological conditions resulting from fungal infection.
    Type: Grant
    Filed: October 14, 1999
    Date of Patent: March 17, 2009
    Assignee: Oscient Pharmaceuticals Corporation
    Inventors: Keith G. Weinstock, David Bush
  • Nucleic acid and amino acid sequences relating to for diagnostics and therapeutics
    Patent number: 7041814
    Abstract: The invention provides isolated polypeptide and nucleic acid sequences derived from Enterobacter cloacae that are useful in diagnosis and therapy of pathological conditions; antibodies against the polypeptides; and methods for the production of the polypeptides. The invention also provides methods for the detection, prevention and treatment of pathological conditions resulting from bacterial infection.
    Type: Grant
    Filed: February 18, 1999
    Date of Patent: May 9, 2006
    Assignee: Genome Therapeutics Corporation
    Inventors: Keith G. Weinstock, Craig Deloughery, David Bush
  • Nucleic acid sequences relating to Candida albicans for diagnostics and therapeutics
    Patent number: 6747137
    Abstract: The invention provides isolated polypeptide and nucleic acid sequences derived from Candida albicans that are useful in diagnosis and therapy of pathological conditions; antibodies against the polypeptides; and methods for the production of the polypeptides. The invention also provides methods for the detection, prevention and treatment of pathological conditions resulting from fungal infection.
    Type: Grant
    Filed: February 12, 1999
    Date of Patent: June 8, 2004
    Assignee: Genome Therapeutics Corporation
    Inventors: Keith G. Weinstock, David Bush